AWARDBPA CALLOther than small business
BPA call 75F40120F19001DELOITTE & TOUCHE LLP
Overview
Award facts
- Net obligations
- $7.33M
- $7,328,325of $7.33M potential value
- Outlays (paid to date)
- $5.89M
- $5.89M paid of $7.33M obligated$5,886,155
- Period of performance
- Aug 14, 2020 to May 14, 2025
- Ended
- Modifications
- 8
- Latest action Jun 17, 2025
- Contract type
- BPA call
- PIID 75F40120F19001
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
INTERNAL CONTROLS ORDER
Dates and value
- Award date
- Signed on Aug 14, 2020
- Potential end of performance
- May 13, 2025
- Current value
- $7,328,325Base and exercised options
- Potential value (if all options are exercised)
- $7,328,325
- Parent contract vehicle
- 75F40120A00023 (BPA, single award) — 10 orders recorded under it
Obligations by fiscal year of action
- FY2025: -$1,013,342 (de-obligation)
- FY2024: $1,823,615
- FY2023: $1,787,834
- FY2022: $1,752,768
- FY2021: $1,718,400
- FY2020: $1,259,050
Total across 6 fiscal years: $7,328,325
Net de-obligation in that fiscal year (obligations withdrawn).
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jun 17, 2025. View on USAspending · Recipient on SAM.gov
Recipient
LocationARLINGTON, VA
UEIF9KSDU7L9VP6
CAGE code3CCJ5
Business sizeOther than small businessSize at award, per the contracting officer
Organization typePartnership
Parent companyDELOITTE CONSULTING LLP
Business types and certifications
For-profit organizationPartnership or LLP
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded from
- Fda working capital fundProgram activities075-4613Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Arlington, Virginia 22209-1742
- Congressional district (place of performance)
- VA-08As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- R703SUPPORT- MANAGEMENT: ACCOUNTING (service)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Subject to multiple award fair opportunityMAFO
- Set-aside
- Not reported
- Contract pricing
- Labor hoursZ
Contract details
- Service Contract Act labor standards
- Yes
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Aug 14, 2020Base obligation at award: $1,259,050
- Latest action
- Jun 17, 2025 — CloseoutModification P00008; obligation change -$1,013,342; administrative: no change in scope or value
- Latest substantive action
- Mar 31, 2025 — Terminated for convenienceModification P00007
- Actions by type
- Base award1
- Option exercised4
- Supplemental agreement (within scope)1
- Terminated for convenience1
- Closeout1
- Other administrative action1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- -$1,013,342
- Latest action: change in base and all options
- -$1,013,342
Socio-economic and policy
- Inherently governmental functions
- Critical functionsCT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- BPA callA
- Parent vehicle type
- BPAE
- Parent vehicle: multiple or single award
- Single awardS
- Parent vehicle agency
- Food And Drug Administration7524
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7524
- Contracting office code
- 75F401
- Transactions recorded under this award key
- 9
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7524
- Funding office code
- 75F401
- Treasury accounts
- 075-X-4613-000
- Object classes
- 25.2: Other services from non-Federal sources
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression